statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Genetron Health Completes Privatization Process

Genetron Holdings Ltd (GTH) has released an update. Genetron Holdings Limited, a leader in China's precision oncology sector, has completed its tra...

Genetron Health Announces Completion of Going Private Transaction

BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ( Genetron Health or the Company , Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...

Genetron Holdings (GTH, $3.91) entered Downtrend as Momentum indicator drops below 0 level on Mar 14, 2024

This indicator may be signaling that GTH's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Genetron Holdings (GTH, $3.88) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 6, 2024

This is a Bearish indicator signaling GTH's price could decline from here. Traders may explore shorting the stock or put options...

Genetron Holdings (GTH, $3.88) entered Downtrend as Momentum indicator drops below 0 level on Mar 06, 2024

Genetron Health Announces Shareholders' Approval of Merger Agreement

BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ( Genetron Health or the Company , NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...

Short Interest in Genetron Holdings Limited (NASDAQ:GTH) Expands By 58.5%

Genetron Holdings Limited (NASDAQ:GTH  Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling...

Genetron Holdings (GTH, $3.77) price may climb as it broke lower Bollinger Band on Feb 07, 2024

This price move could be a signal that GTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Genetron Holdings (GTH, $3.79) entered Downtrend as Momentum indicator drops below 0 level on Feb 06, 2024

Genetron Holdings (GTH, $3.8) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 1, 2024

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.

Volume	412,603.00
52-Wk High	$4.05
52-Wk Low	$2.08

Current Price	$4.03
Prev Close	$4.02
Open	$4.02
Dividend Yield	N/A
50-Day Moving Average	$4.03
Beta	0.73
Avg. Volume	0.00
PE Ratio	N/A

52-Week High	$4.05
52-Week Low	$2.08
Market Capitalization	$122.62M
EPS	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

GTH Genetron Holdings Ltd - ADR

About

Feed

News

Fundamentals